Germany Trade & Invest Industries
-
Medical Research
-
Pharmaceuticals
Demand for innovative medical technology solutions continues to grow as we live longer, healthier lives. In 2018 spending on medical technology in Germany reached an estimated record high of EUR 36 billion. This creates growth opportunities for the medical technology industry, which in Germany is made up almost entirely of small and medium-sized companies. The positive outlook in the domestic market, combined with strong exports of “Medtech Made in Germany,” resulted in a 10.4 percent...
Combining cutting edge-innovation, a long tradition as the “world´s pharmacy” and continuously growing demand for healthcare products, Germany is the ideal location for pharmaceutical R&D, production, and sales of medicines.Driven by trends such as demographic change, a rise in chronic diseases and an increasing emphasis on prevention and self-medication, Europe’s biggest pharmaceutical market is growing faster than the German economy. Germany belongs to the world’s...
Since 2018, the German Ministry of Health has pushed forward a great amount of legislative actions to digitalize the health care system. In 2019, the German parliament passed the Digital Care Act (DVG) to accelerate digitalization and innovation within the German health care market. The act also paves the way to broad usage and reimbursement of digital health applications – so-called “DIGAs.” These steps open up the German health care market to a digital transformation that will provide 73...
Germany’s biopharmaceuticals sector increased turnover by 14 percent last year, with the country’s biotech companies as important actors in the fight against Covid-19. Germany is the world’s leading medical biotech nation behind the US. The industry’s strength comes from the presence of long-established and start-up companies alike. Industry, government, and the research sector are pulling in one direction to build on the thriving sector’s already strong market foundatio...